Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A randomized, double-blind, placebo- and active comparator-controlled study of rivoglitazone versus pioglitazone in type 2 diabetes mellitus
2007-005263-97Phase 3Terminated
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivoglitazone in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2008; status: terminated.
02
Drugs
rivoglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-005263-97.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005263-97.